NPs Basic Information
|
Name |
Stemphol C
|
| Molecular Formula | C21H34O6 | |
| IUPAC Name* |
(2S,3R,4S,5S,6R)-2-(3-butyl-2,4-dihydroxy-6-pentylphenyl)-6-methyloxane-3,4,5-triol
|
|
| SMILES |
CCCCCC1=CC(=C(C(=C1[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O)O)O)O)CCCC)O
|
|
| InChI |
InChI=1S/C21H34O6/c1-4-6-8-9-13-11-15(22)14(10-7-5-2)18(24)16(13)21-20(26)19(25)17(23)12(3)27-21/h11-12,17,19-26H,4-10H2,1-3H3/t12-,17-,19+,20-,21+/m1/s1
|
|
| InChIKey |
BXDSSSHSCHNSBQ-VBDUKTTISA-N
|
|
| Synonyms |
Stemphol C
|
|
| CAS | NA | |
| PubChem CID | 139589437 | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 382.5 | ALogp: | 3.6 |
| HBD: | 5 | HBA: | 6 |
| Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 110.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 27 | QED Weighted: | 0.44 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -5.051 | MDCK Permeability: | 0.00002350 |
| Pgp-inhibitor: | 0.186 | Pgp-substrate: | 0.631 |
| Human Intestinal Absorption (HIA): | 0.705 | 20% Bioavailability (F20%): | 0.952 |
| 30% Bioavailability (F30%): | 0.384 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.042 | Plasma Protein Binding (PPB): | 97.71% |
| Volume Distribution (VD): | 0.883 | Fu: | 2.09% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.193 | CYP1A2-substrate: | 0.775 |
| CYP2C19-inhibitor: | 0.03 | CYP2C19-substrate: | 0.674 |
| CYP2C9-inhibitor: | 0.259 | CYP2C9-substrate: | 0.959 |
| CYP2D6-inhibitor: | 0.387 | CYP2D6-substrate: | 0.335 |
| CYP3A4-inhibitor: | 0.029 | CYP3A4-substrate: | 0.035 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 5.274 | Half-life (T1/2): | 0.678 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.044 | Human Hepatotoxicity (H-HT): | 0.121 |
| Drug-inuced Liver Injury (DILI): | 0.032 | AMES Toxicity: | 0.618 |
| Rat Oral Acute Toxicity: | 0.186 | Maximum Recommended Daily Dose: | 0.054 |
| Skin Sensitization: | 0.925 | Carcinogencity: | 0.031 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.138 |
| Respiratory Toxicity: | 0.368 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003812 |  |
1.000 | D00HCQ |  |
0.294 | ||
| ENC000955 |  |
0.446 | D0O1UZ |  |
0.283 | ||
| ENC004787 |  |
0.390 | D01TNW |  |
0.280 | ||
| ENC000863 |  |
0.385 | D0P1FO |  |
0.269 | ||
| ENC003707 |  |
0.382 | D0L7AS |  |
0.246 | ||
| ENC003582 |  |
0.382 | D06BQU |  |
0.243 | ||
| ENC004773 |  |
0.356 | D0HR8Z |  |
0.242 | ||
| ENC004248 |  |
0.349 | D08DFX |  |
0.240 | ||
| ENC003628 |  |
0.348 | D0H3KI |  |
0.238 | ||
| ENC002935 |  |
0.347 | D0I9HF |  |
0.232 | ||